NCT04216329 2026-01-23
Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
National Institutes of Health Clinical Center (CC)
Phase 1 Active not recruiting
Clinical Trials
11 trialsNCT03432741 2025-05-26
Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer
Mayo Clinic
Phase 1 Terminated
NCT06014905 2025-05-25
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
University of California, San Francisco
Phase 1 Recruiting
NCT04262336 2023-07-06
Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
Decibel Therapeutics
Phase 1 Completed
NCT03177252 2020-10-22
Scalp block
Washington University School of Medicine
Phase 1 Withdrawn
NCT04026321 2019-07-19
Single-dose Escalation Study of SQ-001 Infusion to Characterize the PK Profiles of Major Sentinel Compounds in Healthy Adult Volunteers in US
Livzon Pharmaceutical Group Inc.
Phase 1 Completed
NCT02889848 2019-07-10
Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)
Advance Biofactures Corporation
Phase 1 Completed
NCT00693095 2018-01-30
ERaDICATe
Duke University
Phase 1 Completed
NCT00278434 2017-11-24
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
University of California, San Francisco
Phase 1 Terminated
NCT00294203 2014-04-15
Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer
University of Florida
Phase 1 Completed
NCT00584597 2010-12-13
TRAUMEEL
University of Oklahoma
Phase 1 Completed